For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).

The request shall include information about a country's bovine spongiform encephalopathy (BSE) case history, risk factors, measures to prevent the introduction and transmission of BSE, and any other information relevant to determining whether specified risk materials, the small intestine of cattle except as provided in paragraph (b)(2) of this section, material from nonambulatory disabled cattle, or MS (Beef) from cattle from the country should be considered prohibited cattle materials. FDA shall respond in writing to any such request and may impose conditions in granting any such request.

Subpart C—Substances Generally Prohibited From Direct Addition or Use as Human Food (§§ 189.110 - 189.191) · Subpart D—Substances Prohibited From Indirect Addition to Human Food Through Food-Contact Surfaces (§§ 189.220 - 189.301) · ...

For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).

March 26, 2021 - [21] 21 CFR 189.110. [22] “U.S. Orders Hearings on 3 Food Colorings.” Associated Press/New York Times, December 19, 1953. [23] Gardiner Harris, “F.D.A. Panel to Consider Warnings for Artificial Food Colorings.” New York Times, March 29, 2011. See also Deborah Blum, “A Poisoner’s Tale of Halloween.” Wired, October 31, 2012.

For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).

For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).

The Code of Federal Regulations (CFR) is the official legal print publication containing the codification of the general and permanent rules published in the Federal Register by the departments and agencies of the Federal Government. The Electronic Code of Federal Regulations (eCFR) is a continuously updated online version of the CFR.

For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).

For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).

March 28, 2023 - The information used to document and to corroborate the history and circumstances of use of the substance must be generally available; that is, it must be widely available in the country in which the history of use has occurred and readily available to interested qualified experts in the United ...

It is not an official legal edition of the CFR.

August 15, 2024 - Food packaging manufacturers must prove to the FDA that all materials in contact with food are safe before they are permitted for use in such a manner. Authorized direct and indirect food additives can be found in the food additives regulations, ...

January 6, 2025 - This guidance, when finalized, will describe considerations for complying with the requirements in 21 CFR 211.110 to ensure batch uniformity and drug product integrity. In addition, this guidance discusses related quality considerations for drug products that are manufactured using advanced manufacturing.

Press Releases and Statements

The CGMP regulation established ... 20, 1968). In 1973, we amended the CGMP regulation by adding a new section regarding natural or unavoidable defect levels in foods. (38 FR 854, January 5, 1973). In 1977, we redesignated the CGMP regulation as part 110 (21 CFR part 110) (42 FR 14301 at 14338, March 5, 1977). In the Federal Register of June 19, 1986, FDA issued a final ...

For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).

Side-by-Side Comparison – 21 CFR, Parts 110, 111, 211 and 820 · REGULATIONS Part 110 - CURRENT GOOD

December 30, 2025 - Some critical aspects of the FDA draft guidance include its scope, applicability, and primary focus areas for improving manufacturing and quality control practices. Drug Products Covered: Includes human and veterinary drug products across traditional and advanced manufacturing contexts. Exclusions: APIs and certain specialized drugs, such as PET drugs, which follow separate regulatory standards. ... Outlines regulatory expectations under 21 CFR 211.110 to ensure that in-process materials consistently meet predetermined quality standards.

January 6, 2025 - The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “Considerations for Complying With 21 CFR 211.110.” This guidance, when finalized, will describe considerations for complying with the requirements for ensuring batch uniformity and drug product integrity.